| A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study EC Rossi, LD Kowalski, J Scalici, L Cantrell, K Schuler, RK Hanna, M Ade, ... The Lancet Oncology 18 (3), 384-392, 2017 | 795 | 2017 |
| TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer LA Carey, HS Rugo, PK Marcom, EL Mayer, FJ Esteva, CX Ma, MC Liu, ... Journal of clinical oncology 30 (21), 2615, 2012 | 606 | 2012 |
| Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies RZ Orlowski, PM Voorhees, RA Garcia, MD Hall, FJ Kudrik, T Allred, ... Blood 105 (8), 3058-3065, 2005 | 403 | 2005 |
| A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients SS Carson, JP Kress, JE Rodgers, A Vinayak, S Campbell-Bright, J Levitt, ... Critical care medicine 34 (5), 1326-1332, 2006 | 359 | 2006 |
| Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III GG Schwartz, D Il’yasova, A Ivanova Diabetes care 26 (2), 468-470, 2003 | 347 | 2003 |
| A trial of calcium and vitamin D for the prevention of colorectal adenomas JA Baron, EL Barry, LA Mott, JR Rees, RS Sandler, DC Snover, ... New England Journal of Medicine 373 (16), 1519-1530, 2015 | 326 | 2015 |
| Optimal adaptive designs for binary response trials WF Rosenberger, N Stallard, A Ivanova, CN Harper, ML Ricks Biometrics 57 (3), 909-913, 2001 | 316 | 2001 |
| Risk factors for recurrent urinary tract infection and renal scarring R Keren, N Shaikh, H Pohl, L Gravens-Mueller, A Ivanova, L Zaoutis, ... Pediatrics 136 (1), e13-e21, 2015 | 313 | 2015 |
| Anti-CD30 CAR-T cell therapy in relapsed and refractory Hodgkin lymphoma CA Ramos, NS Grover, AW Beaven, PD Lulla, MF Wu, A Ivanova, T Wang, ... Journal of clinical oncology 38 (32), 3794, 2020 | 288 | 2020 |
| Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring N Shaikh, TK Mattoo, R Keren, A Ivanova, G Cui, M Moxey-Mims, M Majd, ... JAMA pediatrics 170 (9), 848-854, 2016 | 220 | 2016 |
| Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study EC Rossi, A Ivanova, JF Boggess Gynecologic oncology 124 (1), 78-82, 2012 | 220 | 2012 |
| A play-the-winner-type urn design with reduced variability A Ivanova Metrika 58, 1-13, 2003 | 202 | 2003 |
| Minimizing predictability while retaining balance through the use of less restrictive randomization procedures VW Berger, A Ivanova, M Deloria Knoll Statistics in medicine 22 (19), 3017-3028, 2003 | 189 | 2003 |
| Renal scarring in the randomized intervention for children with vesicoureteral reflux (RIVUR) trial TK Mattoo, RW Chesney, SP Greenfield, A Hoberman, R Keren, ... Clinical Journal of the American Society of Nephrology 11 (1), 54-61, 2016 | 155 | 2016 |
| Improved up‐and‐down designs for phase I trials A Ivanova, A Montazer‐Haghighi, SG Mohanty, S D. Durham Statistics in medicine 22 (1), 69-82, 2003 | 153 | 2003 |
| Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial DE Weiner, MA Carpenter, AS Levey, A Ivanova, EH Cole, L Hunsicker, ... American Journal of Transplantation 12 (9), 2437-2445, 2012 | 152 | 2012 |
| Recurrent urinary tract infections in children with bladder and bowel dysfunction N Shaikh, A Hoberman, R Keren, N Gotman, SG Docimo, R Mathews, ... Pediatrics 137 (1), 2016 | 146 | 2016 |
| Two-dimensional dose finding in discrete dose space K Wang, A Ivanova Biometrics 61 (1), 217-222, 2005 | 143 | 2005 |
| Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection EC Rossi, A Jackson, A Ivanova, JF Boggess International Journal of Gynecologic Cancer 23 (9), 2013 | 136 | 2013 |
| Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors TE Stinchcombe, MA Socinski, CM Walko, BH O’Neil, FA Collichio, ... Cancer chemotherapy and pharmacology 60, 759-766, 2007 | 113 | 2007 |
